Literature DB >> 20730795

The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database.

Sophie Lanzkron, C Patrick Carroll, Carlton Haywood.   

Abstract

It is estimated that there are 100,000 people living with sickle-cell disease (SCD) in the United States [1]. The most common manifestation of SCD is vaso-occlusive crisis, which is characterized by intermittent, unexpected episodes of excruciating pain. As these episodes often come on suddenly, much of the care for these crises occurs within emergency departments (EDs). Several studies have examined ED use and costs for certain groups of patients with SCD [2-4]. For example, in 1997, Woods et al. [2] found that 85.7% of 7,202 hospital admissions for SCD in Illinois were for patients that came through the ED, and the total charges for sickle-cell admissions in Illinois were found to be $30 million a year. A recent study of healthcare use by children with SCD demonstrated that children insured by Medicaid had higher ED utilization than those with private insurance (57% vs.45%) [5]. The purpose of our study was to provide national level estimates of ED utilization by SCD patients, which have not previously been available.

Entities:  

Mesh:

Year:  2010        PMID: 20730795      PMCID: PMC3431910          DOI: 10.1002/ajh.21807

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  11 in total

Review 1.  Methods for analyzing health care utilization and costs.

Authors:  P Diehr; D Yanez; A Ash; M Hornbrook; D Y Lin
Journal:  Annu Rev Public Health       Date:  1999       Impact factor: 21.981

2.  Population estimates of sickle cell disease in the U.S.

Authors:  Kathryn L Hassell
Journal:  Am J Prev Med       Date:  2010-04       Impact factor: 5.043

3.  Hospital utilization patterns and costs for adult sickle cell patients in Illinois.

Authors:  K Woods; T Karrison; M Koshy; A Patel; P Friedmann; C Cassel
Journal:  Public Health Rep       Date:  1997 Jan-Feb       Impact factor: 2.792

4.  Utilization of the office, hospital and emergency department for adult sickle cell patients: a five-year study.

Authors:  Kenneth Epstein; Elaine Yuen; Jeff M Riggio; Samir K Ballas; Stephanie M Moleski
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

5.  Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises.

Authors:  L J Benjamin; G I Swinson; R L Nagel
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

6.  Decreasing reimbursements for outpatient emergency department visits across payer groups from 1996 to 2004.

Authors:  Renee Y Hsia; Donna MacIsaac; Laurence C Baker
Journal:  Ann Emerg Med       Date:  2007-11-13       Impact factor: 5.721

7.  Treatment of uncomplicated vaso-occlusive crises in children with sickle cell disease in a day hospital.

Authors:  Jean L Raphael; Aditi Kamdar; M Brooke Beavers; Donald H Mahoney; Brigitta U Mueller
Journal:  Pediatr Blood Cancer       Date:  2008-07       Impact factor: 3.167

8.  Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States.

Authors:  Mercy Mvundura; Djesika Amendah; Patricia L Kavanagh; Philippa G Sprinz; Scott D Grosse
Journal:  Pediatr Blood Cancer       Date:  2009-10       Impact factor: 3.167

9.  Comparison of costs to the health sector of comprehensive and episodic health care for sickle cell disease patients.

Authors:  Y M Yang; A K Shah; M Watson; V N Mankad
Journal:  Public Health Rep       Date:  1995 Jan-Feb       Impact factor: 2.792

10.  The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization.

Authors:  C Patrick Carroll; Carlton Haywood; Peter Fagan; Sophie Lanzkron
Journal:  Am J Hematol       Date:  2009-10       Impact factor: 10.047

View more
  72 in total

1.  Reproductive health choices for young adults with sickle cell disease or trait: randomized controlled trial immediate posttest effects.

Authors:  Diana J Wilkie; Agatha M Gallo; Yingwei Yao; Robert E Molokie; Christine Stahl; Patricia E Hershberger; Zhongsheng Zhao; Marie L Suarez; Robert J Labotka; Bonnye Johnson; Rigo Angulo; Veronica Angulo; Jesus Carrasco; David Shuey; Stephanie Pelligra; Edward Wang; Dennie T Rogers; Alexis A Thompson
Journal:  Nurs Res       Date:  2013 Sep-Oct       Impact factor: 2.381

2.  CE: Understanding the Complications of Sickle Cell Disease.

Authors:  Paula Tanabe; Regena Spratling; Dana Smith; Peyton Grissom; Mary Hulihan
Journal:  Am J Nurs       Date:  2019-06       Impact factor: 2.220

3.  Impact of a Clinical Pharmacy Service on the Management of Patients in a Sickle Cell Disease Outpatient Center.

Authors:  Jin Han; Shubha Bhat; Michel Gowhari; Victor R Gordeuk; Santosh L Saraf
Journal:  Pharmacotherapy       Date:  2016-10-03       Impact factor: 4.705

4.  Communalism Moderates the Association Between Racial Centrality and Emergency Department Use for Sickle Cell Disease Pain.

Authors:  Shawn M Bediako; Chey Harris
Journal:  J Black Psychol       Date:  2017-03-01

5.  The impact of race and disease on sickle cell patient wait times in the emergency department.

Authors:  Carlton Haywood; Paula Tanabe; Rakhi Naik; Mary Catherine Beach; Sophie Lanzkron
Journal:  Am J Emerg Med       Date:  2013-02-04       Impact factor: 2.469

6.  Mechanism-driven phase I translational study of trifluoperazine in adults with sickle cell disease.

Authors:  Robert E Molokie; Diana J Wilkie; Harriett Wittert; Marie L Suarez; Yingwei Yao; Zhongsheng Zhao; Ying He; Zaijie J Wang
Journal:  Eur J Pharmacol       Date:  2013-11-07       Impact factor: 4.432

7.  Exploring Emergency Department Provider Experiences With and Perceptions of Weight-Based Versus Individualized Vaso-Occlusive Treatment Protocols in Sickle Cell Disease.

Authors:  LaʼKita M J Knight; Elijah O Onsomu; Hayden B Bosworth; Regina D Crawford; Theresa DeMartino; Jeffrey Glassberg; Judith A Paice; Christopher N Miller; Lynne Richardson; Paula Tanabe
Journal:  Adv Emerg Nurs J       Date:  2019 Jan/Mar

8.  A preliminary study of psychiatric, familial, and medical characteristics of high-utilizing sickle cell disease patients.

Authors:  Patrick C Carroll; Carlton Haywood; Michelle R Hoot; Sophie Lanzkron
Journal:  Clin J Pain       Date:  2013-04       Impact factor: 3.442

9.  Derivation and preliminary validation of a risk score to predict 30-day ED revisits for sickle cell pain.

Authors:  Jeffrey Glassberg; Jena Simon; Nilesh Patel; Jordan M Jeong; Justin J McNamee; Gary Yu
Journal:  Am J Emerg Med       Date:  2015-07-17       Impact factor: 2.469

10.  Patterns of opioid use in sickle cell disease.

Authors:  Jin Han; Santosh L Saraf; Xu Zhang; Michel Gowhari; Robert E Molokie; Joharah Hassan; Chaher Alhandalous; Shivi Jain; Jewel Younge; Taimur Abbasi; Roberto F Machado; Victor R Gordeuk
Journal:  Am J Hematol       Date:  2016-08-08       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.